Skip to Main Content

Paper Details

High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.
Br J Dermatol
4
2022
Author NameAffiliation
Cynthia L GreenDuke University School of Medicine
  • 1 - 1

Datasets

Release 1.2